This Undiscovered Biotech Stock Has Quintupled in a Year and Just Hit New Highs
AI Sentiment
Positive
6/10
as of 11-28-2025 10:17am EST
Burning Rock Biotech Ltd is a cancer diagnostics company. It is a NGS-based cancer therapy selection company. Its cancer therapy selection platform is built upon advanced proprietary technologies, comprehensive portfolio of products and a two-pronged market-driven commercial infrastructure addressing both larger hospitals through company's in-hospital model and smaller hospitals through its central laboratory model. It had three operating segments, including Central laboratory business, In-hospital business and Pharma research and development services. It generates the majority of its revenue from Central laboratory business. Its products are Pan-HEME, OncoScreen-WES, brPROPHET, OncoScreen Plus, and others.
| Founded: | 2014 | Country: | China |
| Employees: | N/A | City: | N/A |
| Market Cap: | 38.3M | IPO Year: | 2020 |
| Target Price: | N/A | AVG Volume (30 days): | 51.5K |
| Analyst Decision: | N/A | Number of Analysts: | N/A |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -1.60 | EPS Growth: | N/A |
| 52 Week Low/High: | $2.18 - $23.45 | Next Earning Date: | 11-20-2025 |
| Revenue: | $75,749,382 | Revenue Growth: | 5.56% |
| Revenue Growth (this year): | 136.32% | Revenue Growth (next year): | -6.32% |
Machine learning model trained on 25+ technical indicators
Disclaimer: This prediction is generated by an AI model and should not be considered as financial advice. Always conduct your own research and consult with financial professionals before making investment decisions.
BNR Breaking Stock News: Dive into BNR Ticker-Specific Updates for Smart Investing
AI Sentiment
Positive
6/10
See how BNR stacks up against similar companies in the market
Enhance your trading experience with our free tools
The information presented on this page, "BNR Burning Rock Biotech Limited - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.